Advanced Search

National Health (Price and Special Patient Contribution) Amendment Determination 2013 (No. 6)

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$40 per month.
 
PB 62 of 2013
National Health (Price and Special Patient Contribution) Amendment Determination 2013 (No. 6)
National Health Act 1953
I, FELICITY MCNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health and Medical Research, make this Determination under section 85B of the National Health Act 1953.
Dated 6 September 2013
 
 
 
 
 
 
 
 
 
FELICITY MCNEILL
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health and Ageing
 
1          Name of Instrument
            (1)        This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2013 (No. 6).
            (2)        This Instrument may also be cited as PB 62 of 2013.
2          Commencement
            This Instrument commences on 1 October 2013.
3          Amendment of the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)
            Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).
Schedule 1     Amendments
 
[1]       Schedule 1, entry for Doxycycline
omit:
 
Tablet 50 mg (as hydrochloride)
Oral
Vibra-Tabs
25
2.19
3.76
[2]       Schedule 1, entry for Indomethacin
omit from the column headed “Claimed Price”:          3.42        substitute:             3.43
[3]        Schedule 1, entry for Paraffin in the form Pack containing 2 tubes eye ointment, compound, containing white soft paraffin with liquid   paraffin, 3.5 g
omit from the column headed “Brand”:         Lacri-Lube          substitute:             Refresh Night Time
[4]       Schedule 2, omit entry for Zolmitriptan